Medication info
Beazal Tablet 10/50 mg

Beazal Tablet 10/50 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201502672 · Approved 2015.04.30 · Insurance code 694001060

Summary

Main use
Treatment of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or losartan. It is also suitable as initial therapy for patients with stage 2 hypertension who require combination therapy to achieve their target blood pressure. Therefore, it is used to aid effective blood pressure control and improve hypertension management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Hypotension may occur when this medication is first administered to patients with reduced blood volume, so those with such symptoms should be treated beforehand. Patients with known allergies to this medication, pregnant women, those with severe liver dysfunction, severe aortic stenosis, or in a state of shock should not use this medication. Patients requiring reduced blood volume or stringent salt restrictions, moderate to severe renal impairment, or hyperkalemia should use it carefully. Dizziness or headaches may occur during treatment, and side effects such as indigestion or skin rash have been reported. Particularly, taking this medication during pregnancy can lead to serious issues for the fetus, such as decreased renal function, hypotension, and skull malformation, so it is crucial to consult a doctor if planning to become pregnant or if currently pregnant. It is advisable to avoid this medication while breastfeeding as it may be transmitted through breast milk. The safety for elderly patients or children has not been sufficiently established, so caution is necessary. Interactions may occur if taken with other antihypertensive drugs or specific medications, so it is essential to inform your healthcare provider of any other medications being taken. Severe hypotension or heart-related issues may occur in cases of overdose, so the prescribed dosage must be strictly followed, and any abnormal symptoms should be reported to a healthcare provider immediately. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.

Side effects

  • Hypotension
  • neonatal skull molding deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial abnormalities
  • pulmonary hypoplasia
  • preterm
  • intrauterine growth retardation
Show 173 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • itching
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • voiding dysfunction
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • erythema
  • maculopapular rash
  • dizziness
  • heat sensation
  • decreased glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • reduced libido
  • memory impairment
  • migraine
  • neuroexcitability
  • panic disorder
  • sleep disturbances
  • bronchitis
  • throat discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • nocturia
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • abnormal hepatic function
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • hypotension
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.